Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity

被引:46
作者
Heinzel, FP
Rerko, RM
Hujer, AM
机构
[1] Case Western Reserve Univ, Sch Med, Div Geog Med, Cleveland, OH 44106 USA
[2] Vet Affairs Med Ctr, Med Res Serv, Cleveland, OH 44106 USA
关键词
D O I
10.1006/cimm.1998.1267
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin-12 promotes Th1 lymphocyte responses necessary for the cure of murine Leishmania major infection. We found that IL-12 p40 mRNA expression peaked at 4 weeks of infection in resistant C57BL/6 mice at levels threefold greater than in BALB/c mice. Peak IL-12 p40 expression in both strains was reduced threefold following treatment with neutralizing anti-CD40 ligand antibody and disease worsened in C57BL/6 mice. Direct activation of cultured lymph node cells by anti-CD40 MAb or soluble CD40 ligand failed to restore deficient IL-12 production by infected BALB/c mice unless recombinant IFN-gamma was added to culture. Infected BALB/c lymph nodes also contained two-to threefold fewer low-density CD40(+) accessory cells compared to that in C57BL/6 mice, We conclude that CD40-dependent responses are continually required for healing of leishmaniasis and that progressive disease is associated with decreased CD40-stimulated IL-12 synthesis as a consequence of either altered cytokine environment or inadequate accessory cell number. (C) 1998 Academic Press.
引用
收藏
页码:129 / 142
页数:14
相关论文
共 48 条
[1]   CD40 ligand is required for protective cell-mediated immunity to Leishmania major [J].
Campbell, KA ;
Ovendale, PJ ;
Kennedy, MK ;
Fanslow, WC ;
Reed, SG ;
Maliszewski, CR .
IMMUNITY, 1996, 4 (03) :283-289
[2]   Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice [J].
Carrera, L ;
Gazzinelli, RT ;
Badolato, R ;
Hieny, S ;
Muller, W ;
Kuhn, R ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :515-526
[3]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[4]  
CHATELAIN R, 1992, J IMMUNOL, V148, P1182
[5]  
DeKruyff RH, 1997, J IMMUNOL, V158, P359
[6]  
GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533
[7]  
Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984
[8]   PROPERTIES OF MOUSE CD40 - CELLULAR-DISTRIBUTION OF CD40 AND B-CELL ACTIVATION BY MONOCLONAL ANTI-MOUSE CD40 ANTIBODIES [J].
HASBOLD, J ;
JOHNSONLEGER, C ;
ATKINS, CJ ;
CLARK, EA ;
KLAUS, GGB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) :1835-1842
[9]   RECOMBINANT INTERLEUKIN-12 CURES MICE INFECTED WITH LEISHMANIA-MAJOR [J].
HEINZEL, FP ;
SCHOENHAUT, DS ;
RERKO, RM ;
ROSSER, LE ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) :1505-1509
[10]  
HEINZEL FP, 1995, J IMMUNOL, V155, P730